Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges von Shallis, Rory M., Wang, Rong, Davidoff, Amy, Ma, Xiaomei, Zeidan, Amer M.

Volltext

Epidemiology of myelodysplastic syndromes: Why characterizing the beast is a prerequisite to taming it von Zeidan, Amer M., Shallis, Rory M., Wang, Rong, Davidoff, Amy, Ma, Xiaomei

Volltext

Aplastic anemia: Etiology, molecular pathogenesis, and emerging concepts von Shallis, Rory M., Ahmad, Rami, Zeidan, Amer M.

Volltext

Epidemiology of the classical myeloproliferative neoplasms: The four corners of an expansive and complex map von Shallis, Rory M., Wang, Rong, Davidoff, Amy, Ma, Xiaomei, Podoltsev, Nikolai A., Zeidan, Amer M.

Volltext

The genetic and molecular pathogenesis of myelodysplastic syndromes von Shallis, Rory M., Ahmad, Rami, Zeidan, Amer M.

Volltext

Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: A tale of misnomers, controversy and the unresolved von Shallis, Rory M., Gale, Robert P., Lazarus, Hillard M., Roberts, Kenneth B., Xu, Mina L., Seropian, Stuart E., Gore, Steven D., Podoltsev, Nikolai A.

Volltext

Immune checkpoint inhibition in myeloid malignancies: Moving beyond the PD-1/PD-L1 and CTLA-4 pathways von Bewersdorf, Jan Philipp, Shallis, Rory M., Zeidan, Amer M.

Volltext

Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, mult... von Stahl, Maximilian, Shallis, Rory M., Wei, Wei, Montesinos, Pau, Lengline, Etienne, Neukirchen, Judith, Bhatt, Vijaya R., Sekeres, Mikkael A., Fathi, Amir T., Konig, Heiko, Luger, Selina, Khan, Irum, Roboz, Gail J., Cluzeau, Thomas, Martínez-Cuadron, David, Raffoux, Emmanuel, Germing, Ulrich, Umakanthan, Jayadev Manikkam, Mukherjee, Sudipto, Brunner, Andrew M., Miller, Adam, McMahon, Christine M., Ritchie, Ellen K., Rodríguez-Veiga, Rebeca, Itzykson, Raphaël, Boluda, Blanca, Rabian, Florence, Tormo, Mar, Acuña-Cruz, Evelyn, Rabinovich, Emma, Yoo, Brendan, Cano, Isabel, Podoltsev, Nikolai A., Bewersdorf, Jan Philipp, Gore, Steven, Zeidan, Amer M.

Volltext

Epigenetic therapy combinations in acute myeloid leukemia: what are the options? von Bewersdorf, Jan Philipp, Shallis, Rory, Stahl, Maximilian, Zeidan, Amer M.

Volltext

Molecular testing of isolated myeloid sarcoma allows successful FLT3-targeted therapy von Shallis, Rory M., Pucar, Darko, Perincheri, Sudhir, Gore, Steven D., Seropian, Stuart E., Podoltsev, Nikolai A., Zeidan, Amer M.

Volltext

The complete story of less than complete responses: The evolution and application of acute myeloid leukemia clinical responses von Shallis, Rory M., Pollyea, Daniel A., Zeidan, Amer M.

Volltext

Management of the Older Patient with Myelodysplastic Syndrome von Shallis, Rory M., Zeidan, Amer M.

Volltext

Multi-institutional study evaluating clinical outcome with allogeneic hematopoietic stem cell transplantation after blinatumomab in patients with B-cell acute lymphoblastic leukemi... von Badar, Talha, Szabo, Aniko, Litzow, Mark, Burkart, Madelyn, Yurkiewicz, Ilana, Dinner, Shira, Hefazi, Mehrdad, Shallis, Rory M., Podoltsev, Nikolai, Patel, Anand A., Curran, Emily, Wadleigh, Martha, Balasubramanian, Suresh, Yang, Jay, Arslan, Shukaib, Aldoss, Ibrahim, Mattison, Ryan, Cenin, Danielle, Siebenaller, Caitlin, Advani, Anjali, Liedtke, Michaela, Atallah, Ehab

Volltext

A clandestine culprit with critical consequences: Benzene and acute myeloid leukemia von Shallis, Rory M., Weiss, Julian J., Deziel, Nicole C., Gore, Steven D.

Volltext

Prognostic implications of mono-hit and multi-hit TP53 alterations in patients with acute myeloid leukemia and higher risk myelodysplastic syndromes treated with azacitidine-based... von Zeidan, Amer M., Bewersdorf, Jan Philipp, Hasle, Vanessa, Shallis, Rory M., Thompson, Ethan, de Menezes, Daniel Lopes, Rose, Shelonidta, Boss, Isaac, Halene, Stephanie, Haferlach, Torsten, Fox, Brian

Volltext

Changes in intestinal microbiota and their effects on allogeneic stem cell transplantation von Shallis, Rory M., Terry, Christopher M., Lim, Seah H.

Volltext

Treatment patterns and real-world effectiveness of rituximab maintenance in older patients with mantle cell lymphoma: a population-based analysis von Di, Mengyang, Long, Jessica B, Kothari, Shalin K, Sethi, Tarsheen, Zeidan, Amer M, Podoltsev, Nikolai A, Shallis, Rory M, Wang, Rong, Ma, Xiaomei, Huntington, Scott F

Volltext

The minimal that kills: Why defining and targeting measurable residual disease is the “Sine Qua Non” for further progress in management of acute myeloid leukemia von Bewersdorf, Jan Philipp, Shallis, Rory M., Boddu, Prajwal C., Wood, Brent, Radich, Jerald, Halene, Stephanie, Zeidan, Amer M.

Volltext

Myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U): More than just a “catch-all” term? von Shallis, Rory M., Zeidan, Amer M.

Volltext

Cost-effectiveness of liposomal cytarabine/daunorubicin in patients with newly diagnosed acute myeloid leukemia von Bewersdorf, Jan Philipp, Patel, Kishan K., Goshua, George, Shallis, Rory M., Podoltsev, Nikolai A., Huntington, Scott F., Zeidan, Amer M.

Volltext